Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism Akt-1 inhibitors(Serine/threonine-protein kinase AKT inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Myeloid Leukemia | Preclinical | IT | 26 Oct 2022 |